Abstract:16510 Background: Epidermal growth factor receptor (EGFR) overexpression is proved to be an independent predictor of poor clinical outcome in Nasopharyngeal Carcinoma (NPC). Expression level of EGFR is also important for EGFR-Targeted therapy but yet unexplored in the primary NPC tumors and lymph node metastases. Aim of this study was to correlate EGFR expression levels in primary tumors and lymph node metastases in NPC to find out whether assessing EGFR status on primary cancer is an effective tool for planning EGFR targeted therapy. Methods: Archived tissue samples of primary tumor and corresponding lymph node metastases of 86 NPC patients (67 males, 19 females; median age = 52 years) diagnosed between 1997 and 2006 were collected from Sun Yat-sen University Cancer Center. Immunohistochemical evaluation of EGFR expression in primary tumors and related lymph node metastasis was performed. According to the UICC 2002 staging system for nasopharyngeal carcinoma, stages Iib, III, IVa, IVb and IVc included 43, 11, 3, 27 and 2 cases respectively. Cervical and supraclavicular lymph nodes were taken in 66 (76.7%) and 20 patients (23.3%) respectively. EGFR status was defined as positive if the percentage of malignant cells stained were =1%. The SPSS 10.0 system was used for statistical analysis and Chi- square test was used to assess the correlation between the EGFR expression in the primary and metastatic tumors. Results: EGFR status was positive in 63 primary tumors (73.2%) and 52 metastatic lymph nodes(60.5%). In 18 EGFR expressing primary tumors (28.6%), the corresponding metastatic lymph node site was negative whereas it was found positive in 7 metastic lymph node (13.5%) of EGFR-negative primary tumors. The difference between these two groups (ie, EGFR-positive to EGFR-negative vs. EGFR-negative to EGFR-positive) was statistically significant (P=0.001). Conclusions: High levels of EGFR protein are frequently observed in NPC and represent potential therapeutic target. However, equivalent expression is not displayed by metastatic nodes, which may limit the effectiveness of anti- EGFR treatment in advanced diseases. These findings have to be considered in future prospective studies. No significant financial relationships to disclose.

Egfr, Her2 and Her3 Expression in Esophageal Primary Tumours and Corresponding Metastases

Egfr and Her2 Expression in Primary Cervical Cancers and Corresponding Lymph Node Metastases: Implications for Targeted Radiotherapy

EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases

Comparison of the Epidermal Growth Factor Receptor Protein Expression Between Primary Non-Small Cell Lung Cancer and Paired Lymph Node Metastases: Implications for Targeted Nuclide Radiotherapy.

Her2 Expression in Primary Gastric Cancers and Paired Synchronous Lymph Node and Liver Metastases. A Possible Road to Target Her2 with Radionuclides

Epidermal Growth Factor Receptor and Human Epidermal Growth Receptor 2 Expression in Parotid Mucoepidermoid Carcinoma: Possible Implications for Targeted Therapy.

The Expression of EGFR by Immunohistochemical Staining to Predict the Response of Nimotuzumab in Esophageal Squamous Cell Carcinoma.

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma

Expression of EGFR,GST-π and C-erbB-2 in esophageal squamous cell carcinoma and their clinical significance

Prevalence of Gene Amplifications of Sox-2, C-Met, and Fgfr1 in Asian Patients with Esophageal Squamous Cell Carcinoma.

Epidermal Growth Factor Receptor and B7-H3 Expression in Esophageal Squamous Tissues Correlate to Patient Prognosis.

EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer

The Prognostic Value of EGFR Overexpression and Amplification in Esophageal Squamous Cell Carcinoma

Evaluation Of Epidermal Growth Factor Receptor (Egfr) In Nasopharyngeal Carcinoma And Lymph Node Metastases: Implications For Egfr Targeted Therapy

Preclinical Evaluation of a Novel EGFR&c-Met Bispecific Near Infrared Probe for Visualization of Esophageal Cancer and Metastatic Lymph Nodes.

Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.

The Study of HER2 Protein Expression and Gene Amplification in Esophageal Squamous Cell Carcinoma

Expression of Egfr, Her2 Predict Lymph Node Metastasis (Lnm)-Associated Metastasis in Colorectal Cancer

Prognostic Value of EGFR Family Expression in Lymph Node-Negative Esophageal Squamous Cell Carcinoma Patients.

C-Met As a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome